For help on how to get the results you want, see our search tips.
1581 results
Categories
Human Remove Human filter
-
List item
Human medicine European public assessment report (EPAR): Renagel (updated)
sevelamer, Renal Dialysis; Hyperphosphatemia
Date of authorisation: 28/01/2000, Revision: 34, Authorised, Last updated: 03/12/2021 -
List item
Human medicine European public assessment report (EPAR): Axumin (updated)
Fluciclovine (18F), Prostatic Neoplasms; Radionuclide Imaging
Date of authorisation: 21/05/2017,
, Revision: 13, Authorised, Last updated: 03/12/2021
-
List item
Human medicine European public assessment report (EPAR): Ultomiris (updated)
ravulizumab, Hemoglobinuria, Paroxysmal
Date of authorisation: 02/07/2019,, Revision: 7, Authorised, Last updated: 03/12/2021
-
List item
Human medicine European public assessment report (EPAR): Atectura Breezhaler (updated)
indacaterol acetate, Mometasone furoate, Asthma
Date of authorisation: 30/05/2020, Revision: 3, Authorised, Last updated: 03/12/2021 -
List item
Human medicine European public assessment report (EPAR): Lamivudine Teva Pharma B.V. (updated)
lamivudine, HIV Infections
Date of authorisation: 10/12/2009,
, Revision: 17, Authorised, Last updated: 03/12/2021
-
List item
Human medicine European public assessment report (EPAR): RoActemra (updated)
tocilizumab, Arthritis, Rheumatoid; Arthritis, Juvenile Rheumatoid
Date of authorisation: 15/01/2009, Revision: 35, Authorised, Last updated: 03/12/2021 -
List item
Human medicine European public assessment report (EPAR): Fareston (updated)
toremifene, Breast Neoplasms
Date of authorisation: 14/02/1996, Revision: 24, Authorised, Last updated: 03/12/2021 -
List item
Human medicine European public assessment report (EPAR): Aripiprazole Accord (updated)
aripiprazole, Schizophrenia; Bipolar Disorder
Date of authorisation: 15/11/2015,, Revision: 12, Authorised, Last updated: 03/12/2021
-
List item
Human medicine European public assessment report (EPAR): Vaxzevria (previously COVID-19 Vaccine AstraZeneca) (updated)
ChAdOx1-SARS-COV-2, COVID-19 virus infection
Date of authorisation: 29/01/2021,, 
, Revision: 17, Authorised, Last updated: 03/12/2021
-
List item
Human medicine European public assessment report (EPAR): Rapamune (updated)
Sirolimus, Graft Rejection; Kidney Transplantation
Date of authorisation: 13/03/2001, Revision: 44, Authorised, Last updated: 03/12/2021 -
List item
Human medicine European public assessment report (EPAR): Incresync (updated)
alogliptin, pioglitazone, Diabetes Mellitus, Type 2
Date of authorisation: 19/09/2013, Revision: 12, Authorised, Last updated: 03/12/2021 -
List item
Human medicine European public assessment report (EPAR): Qtern (updated)
Saxagliptin, dapagliflozin propanediol monohydrate, Diabetes Mellitus, Type 2; Diabetes Mellitus; Nutritional and Metabolic Diseases; Metabolic Diseases; Glucose Metabolism Disorders
Date of authorisation: 15/07/2016, Revision: 8, Authorised, Last updated: 02/12/2021 -
List item
Human medicine European public assessment report (EPAR): Teysuno (updated)
tegafur, gimeracil, oteracil, Stomach Neoplasms
Date of authorisation: 14/03/2011,
, Revision: 19, Authorised, Last updated: 02/12/2021
-
List item
Human medicine European public assessment report (EPAR): Blitzima (updated)
rituximab, Lymphoma, Non-Hodgkin; Leukemia, Lymphocytic, Chronic, B-Cell
Date of authorisation: 13/07/2017,, 
, Revision: 12, Authorised, Last updated: 02/12/2021
-
List item
Human medicine European public assessment report (EPAR): Vidaza (updated)
azacitidine, Myelodysplastic Syndromes
Date of authorisation: 17/12/2008,
, Revision: 23, Authorised, Last updated: 02/12/2021
-
List item
Human medicine European public assessment report (EPAR): Gencebok (updated)
Caffeine citrate, Apnea
Date of authorisation: 19/08/2020, Revision: 5, Authorised, Last updated: 02/12/2021 -
List item
Human medicine European public assessment report (EPAR): Hexacima (updated)
hepatitis B surface antigen, Diphtheria toxoid, tetanus toxoid, Bordetella pertussis antigens Pertussis Toxoid Filamentous Haemagglutinin, poliovirus (inactivated) type 1 (Mahoney) type 2 (MEF-1) type 3 (Saukett), Haemophilus influenzae type b polysaccharide (Polyribosylribitol Phosphate) conjugated to Tetanus protein, Hepatitis B; Tetanus; Immunization; Meningitis, Haemophilus; Whooping Cough; Poliomyelitis; Diphtheria
Date of authorisation: 17/04/2013,
Date of refusal: 22/02/2013, Revision: 24, Authorised, Last updated: 02/12/2021 -
List item
Human medicine European public assessment report (EPAR): Stivarga (updated)
regorafenib, Colorectal Neoplasms
Date of authorisation: 26/08/2013, Revision: 17, Authorised, Last updated: 02/12/2021 -
List item
Human medicine European public assessment report (EPAR): Iclusig (updated)
ponatinib, Leukemia, Myeloid; Leukemia, Lymphoid
Date of authorisation: 01/07/2013,, , 
, Revision: 22, Authorised, Last updated: 02/12/2021
-
List item
Human medicine European public assessment report (EPAR): Hexyon (updated)
filamentous haemagglutinin, Haemophilus influenzae type B polysaccharide (polyribosylribitol phosphate), hepatitis B surface antigen, pertussis toxoid, poliovirus (inactivated) type 1 (Mahoney strain) produced on Vero cells, poliovirus (inactivated) type 2 (MEF-1 strain) produced on Vero cells, poliovirus (inactivated) type 3 (Saukett strain) produced on Vero cells, tetanus protein, tetanus toxoid adsorbed on aluminium hydroxide, hydrated, Diphtheria toxoid, Hepatitis B; Tetanus; Immunization; Meningitis, Haemophilus; Whooping Cough; Poliomyelitis; Diphtheria
Date of authorisation: 17/04/2013,
Date of refusal: 22/02/2013, Revision: 25, Authorised, Last updated: 02/12/2021 -
List item
Human medicine European public assessment report (EPAR): Renvela (updated)
sevelamer carbonate, Hyperphosphatemia; Renal Dialysis
Date of authorisation: 09/06/2009, Revision: 23, Authorised, Last updated: 02/12/2021 -
List item
Human medicine European public assessment report (EPAR): Lynparza (updated)
Olaparib, Ovarian Neoplasms
Date of authorisation: 16/12/2014, Revision: 16, Authorised, Last updated: 02/12/2021 -
List item
Human medicine European public assessment report (EPAR): Cabometyx (updated)
cabozantinib (s)-malate, Carcinoma, Renal Cell; Carcinomas, Hepatocellular
Date of authorisation: 09/09/2016,, Revision: 13, Authorised, Last updated: 01/12/2021
-
List item
Human medicine European public assessment report (EPAR): Lantus (updated)
insulin glargine, Diabetes Mellitus
Date of authorisation: 09/06/2000, Revision: 37, Authorised, Last updated: 01/12/2021 -
List item
Human medicine European public assessment report (EPAR): Inflectra (updated)
infliximab, Arthritis, Psoriatic; Spondylitis, Ankylosing; Colitis, Ulcerative; Psoriasis; Crohn Disease; Arthritis, Rheumatoid
Date of authorisation: 10/09/2013,, Revision: 28, Authorised, Last updated: 01/12/2021